N-acyl dopamine derivates as lead compound for implementation in transplantation medicine

Conjugates of fatty acids with ethanolamine, amino acids or monoamine neurotransmitters occur widely in nature giving rise to so-called endocannabinoids. Anandamide and 2-arachidonoyl glycerol are the best characterized endocannabinoids activating both cannabinoid receptors (CB1 and CB2) and transie...

Full description

Saved in:
Bibliographic Details
Main Authors: Wedel, Johannes (Author) , Yard, Benito A. (Author)
Format: Article (Journal)
Language:English
Published: July 2015
In: Transplantation reviews
Year: 2015, Volume: 29, Issue: 3, Pages: 109-113
ISSN:1557-9816
DOI:10.1016/j.trre.2014.12.004
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.trre.2014.12.004
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0955470X14001189
Get full text
Author Notes:Johannes Wedel, Prama Pallavi, Eleni Stamellou, Benito A. Yard
Description
Summary:Conjugates of fatty acids with ethanolamine, amino acids or monoamine neurotransmitters occur widely in nature giving rise to so-called endocannabinoids. Anandamide and 2-arachidonoyl glycerol are the best characterized endocannabinoids activating both cannabinoid receptors (CB1 and CB2) and transient receptor potential vanilloid type 1 (TRPV1) channels (anandamide) or activating cannabinoid receptors only (2-arachidonoyl glycerol). TRPV1 is also activated by vanilloids, such as capsaicin, and endogenous neurolipins, e.g. N-arachidonoyl dopamine (NADA) and N-oleoyl dopamine (OLDA). Because donor dopamine treatment has shown to improve transplantation outcome in renal and heart recipients, this review will mainly focus on the biological activities of N-acyl dopamine derivates (NADD) as potential non-hemodynamic alternative for implementation in transplantation medicine. Hence the influence of NADD on transplantation relevant entities, i.e. cold inflicted injury, cytoprotection, I/R-injury, immune-modulation and inflammation will be summarized. The cytoprotective properties of endogenous endocannabinoids in this context will be briefly touched upon.
Item Description:Gesehen am 15.03.2018
Physical Description:Online Resource
ISSN:1557-9816
DOI:10.1016/j.trre.2014.12.004